<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">56612</article-id><article-id pub-id-type="doi">10.7554/eLife.56612</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Systemic hypoxia inhibits T cell response by limiting mitobiogenesis via matrix substrate-level phosphorylation arrest</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-179392"><name><surname>Saragovi</surname><given-names>Amijai</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179395"><name><surname>Abramovich</surname><given-names>Ifat</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179494"><name><surname>Omar</surname><given-names>Ibrahim</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179493"><name><surname>Arbib</surname><given-names>Eliran</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179492"><name><surname>Toker</surname><given-names>Ori</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179495"><name><surname>Gottlieb</surname><given-names>Eyal</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-166050"><name><surname>Berger</surname><given-names>Michael</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3469-0076</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Immunology and Cancer Research</institution>, <institution>Hebrew University</institution>, <addr-line><named-content content-type="city">Jerusalem</named-content></addr-line>, <country>Israel</country></aff><aff id="aff2"><institution content-type="dept">The Ruth and Bruce Rappaport Faculty of Medicine</institution>, <institution>Technion - Israel Institute of Technology</institution>, <addr-line><named-content content-type="city">Haifa</named-content></addr-line>, <country>Israel</country></aff><aff id="aff3"><institution content-type="dept">Faculty of Medicine</institution>, <institution>Hebrew University of Jerusalem</institution>, <addr-line><named-content content-type="city">Jerusalem</named-content></addr-line>, <country>Israel</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-4853"><name><surname>Rath</surname><given-names>Satyajit</given-names></name><role>Reviewing editor</role><aff><institution>Indian Institute of Science Education and Research (IISER)</institution>, <country>India</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>michaelb@ekmd.huji.ac.il</email> (MB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>23</day><month>11</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e56612</elocation-id><history><date date-type="received"><day>03</day><month>03</month><year>2020</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>Â© 2020, Saragovi et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Saragovi et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-56612-v2.pdf"/><abstract><p>Systemic oxygen restriction (SOR) is prevalent in numerous clinical conditions, including chronic obstructive pulmonary disease (COPD),and is associated with increased susceptibility to viral infections. However, the influence of SOR on T cell immunity remains uncharacterized. Here we show the detrimental effect of hypoxia on mitochondrial-biogenesis in activated mouse CD8<sup>+</sup> T cells. We find that low oxygen level diminishes CD8<sup>+</sup> T cell viral response in vivo. We reveal that respiratory restriction inhibits ATP-dependent matrix processes that are critical for mitochondrial biogenesis. This respiratory restriction-mediated effect could be rescued by TCA cycle re-stimulation, which yielded increased mitochondrial matrix-localized ATP via substrate-level phosphorylation. Finally, we demonstrate that the hypoxia-arrested CD8<sup>+</sup> viral response could be rescued in vivo through brief exposure to atmospheric oxygen pressure. Overall, these findings elucidate the detrimental effect of hypoxia on mitochondrial-biogenesis in activated CD8<sup>+</sup> T cells, and suggest a new approach for reducing viral infections in COPD.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Israeli Science Foundation</institution></institution-wrap></funding-source><award-id>Personal grant,1596/17</award-id><principal-award-recipient><name><surname>Berger</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>German Israeli Foundation for Scientific Research and Development</institution></institution-wrap></funding-source><award-id>I-1474-414.13/2018</award-id><principal-award-recipient><name><surname>Berger</surname><given-names>Michael</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the guidelines of the institutional ethics committee (AAALAC standard). The protocols were approved by the Committee on the Ethics of Animal Experiments of the Hebrew University (Ethics Committee - research number: MD-16-14863-1 and MD-18-15662-5). Every effort was made to minimize suffering.</p></fn><fn fn-type="other"><p>Human subjects: Human blood samples were obtained via Shaare Zedek Medical Center Jerusalem, Helsinki committee approval number: 143/14</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Metabolic analysis data and Protein MS analysis have been deposited in OSF under DOI 10.17605/OSF.IO/JKMQF</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Saragovi Amijai</collab><collab>Abramovitch Ifat</collab><collab>Omar Ibrahim</collab><collab>Arbib Eliran</collab><collab>Toker Ori</collab><collab>Gottlieb Eyal</collab><collab>Berger Michael</collab></person-group><year iso-8601-date="2020">2020</year><source>Metabolic Tracing of activated T cells</source><ext-link ext-link-type="uri" xlink:href="https://osf.io/67wnx/">https://osf.io/67wnx/</ext-link><comment>DOI 10.17605/OSF.IO/JKMQF</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Saragovi Amijai</collab><collab>Abramovitch Ifat</collab><collab>Omar Ibrahim</collab><collab>Arbib Eliran</collab><collab>Toker Ori</collab><collab>Gottlieb Eyal</collab><collab>Berger Michael</collab></person-group><year iso-8601-date="2020">2020</year><source>MS analysis of anti-ubiquitin precipitated proteins from oligomycin treated T cells</source><ext-link ext-link-type="uri" xlink:href="https://osf.io/u7f92/">https://osf.io/u7f92/</ext-link><comment>DOI 10.17605/OSF.IO/JKMQF</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-56612-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>